Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Get Free Report) was the target of a large decline in short interest in August. As of August 31st, there was short interest totaling 238 shares, a decline of 40.5% from the August 15th total of 400 shares. Based on an average daily trading volume, of 2,022 shares, the short-interest ratio is presently 0.1 days. Currently, 0.1% of the company’s stock are sold short.
Innovator IBD Breakout Opportunities ETF Stock Performance
BOUT stock remained flat at $43.38 during trading on Friday. The company had a trading volume of 2,669 shares, compared to its average volume of 3,723. The firm has a market capitalization of $43.34 million, a price-to-earnings ratio of 28.69 and a beta of 1.02. The business’s fifty day simple moving average is $45.30 and its 200 day simple moving average is $44.48. Innovator IBD Breakout Opportunities ETF has a fifty-two week low of $35.05 and a fifty-two week high of $49.41.
Institutional Trading of Innovator IBD Breakout Opportunities ETF
A hedge fund recently raised its position in Innovator IBD Breakout Opportunities ETF stock. Comprehensive Wealth Management LLC increased its holdings in shares of Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT – Free Report) by 122.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 23,403 shares of the company’s stock after purchasing an additional 12,859 shares during the quarter. Comprehensive Wealth Management LLC owned 6.69% of Innovator IBD Breakout Opportunities ETF worth $850,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Innovator IBD Breakout Opportunities ETF Company Profile
The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.
See Also
- Five stocks we like better than Innovator IBD Breakout Opportunities ETF
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
- Braze Beat Expectations—Now 2 SaaS Peers Are in Focus
- 3 Zero-Fee ETFs Worth More Than Their Cost
- 3 Nimble Free Cash Flow Names With Light Assets
Receive News & Ratings for Innovator IBD Breakout Opportunities ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD Breakout Opportunities ETF and related companies with MarketBeat.com's FREE daily email newsletter.
